FRES
Fresh2 Group Limited Sponsored ADR Class A · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website fresh2.co
- Employees(FY) 75
- ISIN US03635R3057
Performance
+8.4%
1W
-30.39%
1M
-28.64%
3M
-60.61%
6M
-84.04%
YTD
-86.85%
1Y
Profile
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Technical Analysis of FRES 2024-12-02
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-10-17 04:05
- 2024-08-22 04:05
- 2024-07-15 21:15
- 2024-07-08 04:01
Fresh2 Group Limited Announces 1-for-10 Reverse ADS Split(Globenewswire)
- 2024-06-24 05:14
- 2024-06-06 19:22
- 2024-06-05 19:38
- 2024-06-04 19:35
- 2024-06-03 20:17
Why Is Fresh2 Group (FRES) Stock Up 31% Today?(Investorplace)
- 2024-06-03 19:28
- 2024-05-23 05:18
- 2024-04-21 20:00
- 2024-02-19 20:00
- 2024-01-31 03:38
- 2024-01-03 20:00
- 2023-12-15 03:01
Appointment of New Independent Director(Prnewswire)
- 2023-12-11 20:15
- 2023-07-27 21:00
- 2023-07-25 21:00
- 2023-07-14 00:44
- 2023-06-11 21:00
- 2023-06-04 21:00
Fresh2 Group Ltd. Announces US$4.4 Million Private Placement(Yahoo Finance)
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.